bicarbonate to bring the pH to between 7.0 and 7.4, sterilized by filtration, and further diluted, as needed, in Hanks' balanced salt solution (Hanks and Wallace, 1949) . When two or more compounds were to be used, their solutions were mixed just before injection. The solutions were injected into eggs via the yolk sac, immediately prior to rickettsial inoculation, in a volume of 0.1 ml per egg. Untreated embryos were given the diluent.
Chick embryos. The eggs used were White Leghorn from a flock maintained on an antibioticfree diet. The age of the embryos was 7 or 8 days, the temperature of incubation 35 C, and the period of observation 13 days. Rickettsial suspensions were injected into the yolk sac in volumes of 0.4 ml per egg.
Determinations of the effect of chemicals were made by comparing mean survival times of control and treated groups of embryos. Most groups were composed of approximately 20 embryos, exclusive of those which died because of injection trauma. Yolk sacs from approximately one fourth of the embryos were smeared and checked for the presence of rickettsiae. The few embryos surviving at 13 days were arbitrarily given 14 as the day of death. Some of the compounds were toxic in high concentration and tended to reduce embryo survival time. However, interference with rickettsial growth could be demonstrated, even though in some instances it was not possible to separate death due to infection from death due to toxicity.
A statistical analysis of the data obtained in the course of this work indicated that the reliability of the tests was of the same order as that reported by other investigators who have studied chemotherapeutic effects on rickettsial infection in eggs (Ormsbee et al., 1955; Robbins et al., 1951) . On the basis of these analyses, the following guiding criteria can be formulated for the significance of differences in single experiments.
With concentrations of rickettsiae sufficient to kill untreated embryos in approximately 6 days, the least increase in survival time of a group of drug-treated embryos that can be considered as indicating significant protection is 1.0 day. The least difference between two protected groups that can be considered significant is 1.5 days. However, differences are not significant when both protected groups survive at least 4.0 days longer than the control group.
Most of the data presented in this paper are based on experiments repeated two or more times.
EXPERIMENTAL PROCEDURES AND RESULTS
Selection of the p8r strain. The series of egg passages of the parent strain in the presence of p-aminobenzoic acid which had led to the isolation of pr (Weiss et al., 1957) was subsequently utilized for the selection of psr. A pool prepared from the 15th passage, which had been stored at -50 C for over 3 years, was passed once more in the presence of 22,umoles of p-aminobenzoic acid per egg. From this 16th passage PIr was obtained by limit-dilution isolation (see Weiss et al., 1957, for procedure) . As shown in table 1, the susceptibility of this strain to p-aminobenzoic acid appeared to be intermediate between the parent strain and pr.
Reversal of p-aminobenzoic acid inhibition by p-hydroxybenzoic acid. Snyder and Davis (1951) and Takemori and Kitaoka (1952) Parent 5.8-6.6 0.0 0.0 -0.1 pr 5.9-6.6 0.6 1.3 2.7 prr 5.7-6.6
1.0 1.5 2.3 more convincing than in the case of salicylic acid. Because of the higher inhibitory effect of acetylsalicylic acid and its lower toxicity for the chick embryo, it was used for most of thie subsequent experiments in preference to salicylic acid. The p-aminobenzoic acid-resistant strains did not acquire a susceptibility to a number of other related compounds, listed in table 3. However, p-nitrobenzoic acid inhibited all strains tested, including the parent, to a very slight degree.
Strains Qr and pQr were also tested for the susceptibility to acetylsalicylic acid. The former appeared to be resistant, the latter susceptible, providing further confirmation that acetylsalicylic acid susceptibility was associated with the p-aminobenzoic acid marker.
Reversal of acetylsalicylic acid inhibition by p-aminobenzoic acid. The effect of various compounds on inhibition of the rickettsial strains by acetylsalicylic acid was investigated. The sturprising results which were obtained are shown in table 3, figure 1, and table 6. Of the compounds tested only p-aminobenzoic acid reversed the inhibition by acetylsalicylic acid. Figure 1 figure 1 suggest that this inhibition is reversed by p-aminobenzoic acid within a very narrow range of concentration. As the concentration of this drug is increased it rapidly becomes inhibitory. When the four experiments are compared, they indicate that the amount of p-aminobenzoic acid required for reversal increases with the degree of susceptibility of the strain to acetylsalicylic acid. Salicylic acid inhibition of pr and prr was also reversed by p-aminobenzoic acid.
Antagonism between p-hydroxybenzoic and paminobenzoic acid in the reversal of acetylsalicylic acid inhibition. The tests with the isolates, however, cast some doubt on the stability of the third step (from pr to prr) of p-aminobenzoic acid resistance or its phenotypic expression. Therefore, the development of acetylsalicylic acid resistance cannot be held entirely responsible for the reduction in p-aminobenzoic acid resistance of Ar. Table 3 lists the effects of compounds that were tested in attempts to link the observations described in this paper with metabolic steps that have been found to be involved, directly or indirectly, with the action of p-aminobenzoic acid on other microorganisms. Although superficial similarities were found, the experiments suggest some unique features in the metabolism of rickettsiae. A few illustrations of the differences encountered will be given. Emerson and Cushing (1946) and Emerson (1947) isolated a strain of Neurospora, in which the roles of sulfanilamide and p-aminobenzoic acid were reversed, the former compound being the one required and the latter the competitive inhibitor. Zalokar's (1948) experiments indicated that this strain produced more than the tolerated amount of p-aminobenzoic acid and required sulfanilamide as a detoxicant. Table 3 offers evidence that such a mechanism did not operate in our rickettsial strains. Sulfadiazine did not inhibit either strain or reverse the inhibition of the parent strain by p-aminobenzoic acid. It should be noted, however, that the sulfonamide to p-aminobenzoic acid molar ratio of 100:1 required for the reversal of either inhibition in Neurospora was not quite achieved in our tests.
DISCUSSION
The discovery of the tuberculostatic activity of p-aminosalicylic acid (Lehman, 1946) was aided by the report by Bernheim (1941) that sodium salicylate increased the oxygen uptake of tubercle bacilli. However, Youmans et al. (1947) found that p-aminobenzoic acid, and not salicylate, reversed the effect of p-aminosalicylic acid. As shown in table 3, p-aminosalicylic acid had no effect on the rickettsial strains, despite its close structural resemblance to the two active compounds, salicylic and p-aminobenzoic acids.
1959]
The inhibition of microorganisms by salicylic and acetylsalicylic acids has been attributed to interference in a step in pantothenic acid metabolism (IvAnovics, 1942a, b; Maas, 1952) . Our finding that pantothenic acid did not reverse acetylsalicylic acid inhibition was not surprising in view of the report by Kleinschmidt et al. (1956) that purified rickettsiae do not contain significant amounts of pantothenic acid. Davis (1951a) obtained a strain of Escherichia coli with a multiple requirement for tyrosine, phenylalanine, tryptophan, p-aminobenzoic acid, and partial requirement for p-hydroxybenzoic acid. Shikimic acid substituted for the quintuple requirement of this strain, apparently functioning as an early metabolic intermediate. In our studies, as shown in table 3, shikimic acid did not replace either p-hydroxy-or p-aminobenzoic acid in their respective roles as reversers of inhibition.
The work of Morgan (1948 Morgan ( , 1952 offers some interesting points of comparison, because his methods were almost identical to ours. Morgan showed that inhibition of psittacosis virus by sulfadiazine was reversed competitively by p-aminobenzoic acid and noncompetitively by pteroylglutamic acid or citrovorum factor. Colon anid Moulder (1958) obtained conclusive evidence that viruses of the psittacosis group contain folic acid. They have also demonstrated a parallelism between loss of infectivity and loss of folic acid in purified virus suspensions and a markedly slower decline in infectivity in the presence of pteroylglutamic acid in the suspending medium. In our experiments with rickettsiae, pteroylglutamic acid and leucovorin did not replace p-aminobenzoic acid in the reversal of acetylsalicylic acid inhibition. This would indicate that p-aminobenzoic acid is not involved in folic acid metabolism of rickettsiae or that a folic acid different from pteroylglutamic acid or leucovorin is produced. The results of Kleinschmidt et al. (1956) which indicate that rickettsiae do not contain significant amounts of folic acid tend to support the first explanation. Davis (1951b) and Davis and Maas (1952) furnished the most satisfactory bacterial model which can be used as the starting point for an explanation of competitive inhibition in rickettsiae. They isolated a strain of E. coli which required both p-amino-and p-hydroxybenzoic acids. Large concentrations of p-aminobenzoic acid interfered with the utilization of p-hydroxybenzoic acid, but the competition between the two metabolites was not symmetrical. concentrations of p-hydroxybenzoic acid were not inhibitory. p-Nitrobenzoic acid interfered with the utilization of both compounds, being reversed by p-hydroxybenzoic acid plus p-aminobenzoic acid, but not by either compound alone. There are several points of similarity between these results and ours with rickettsiae, including resistance to p-hydroxybenzoic acid and very slight susceptibility to p-nitrobenzoic acid of both parent and prr strains. Figure 2 is an attempt to represent our results based on the above described bacterial model. It takes into consideration the findings of Mathieson and Catcheside (1955) , who have shown that competition may occur not only at the enzymatic site, but also at the site of specific transport. Parent as well as drug-resistant strains are assumed to have (a) an enzymatic site for the attachment and utilization of p-hydroxybenzoic acid, which site also has some affinity for competing p-aminobenzoic acid; (b) a similar site for p-aminobenzoic acid, with affinity for competing acetylsalicylic acid; (c) specific transport systems for p-hydroxybenzoic, p-aminobenzoic, and acetylsalicylic acid.
Strain characteristics are influenced by the relative strengths of the two enzymatic sites. As in the case of the experiments of Mathieson and Catcheside (1955) with Neurospora crassa, it is not necessary to assume that a change has taken place at the sites of specific transport. According to this schema, the enzymatic p-hydroxybenzoic acid site of the parent strain has high affinity for its metabolite and relatively high affinity for competing p-aminobenzoic acid. As the strain mutates to p-aminobenzoic acid resistance, this site loses affinity for its metabolite and competitive inhibitor. This change is accompanied by an increase in affinity of the p-aminobenzoic acid enzymatic site for its metabolite and a corresponding increase for its competitive inhibitor, acetylsalicylic acid. Ar can be visualized as a strain which has lost some affinity at both enzymatic sites. Drug inhibition is produced by two types of competitions: p-hydroxybenzoic-p-aminobenzoic acid and p-aminobenzoic-acetylsalicylic acid. Attempts to show a direct interaction between p-hydroxybenzoic and acetylsalicylic acid have not been successful. However, an indirect action was shown in the presence of p-aminobenzoic acid (see table 7 ). It is necessary to assume that competition may occur at both enzymatic and specific transport sites. Thus, a high concentration of p-aminobenzoic acid interferes with p-hydroxybenzoic acid utilization by the parent strain. Similarly, a high concentration of acetylsalicylic acid interferes with the utilization of p-aminobenzoic acid by prr. p-Hydroxybenzoic acid, although very effectively eliminating p-aminobenzoic inhibition of the parent strain at its own site, has no affinity for the p-aminobenzoic acid site and cannot directly inhibit prr. However, it can compete with p-aminobenzoic acid at the specific transport site, and restore acetylsalicylic acid inhibition when p-aminobenzoic acid acts as a reverser of this inhibition.
The above representation of our results is the simplest of several that we have attempted. Its adequacy must be tested in further experiments.
SUMMARY
Changes associated with the p-aminobenzoic acid resistance of three Madrid E strains of Rickettsia prowazekii, psr pr, and prr, representing first-, second-, and third-step mutants, respectively, were analyzed. Tests were carried out with 7-to 8-day-old chick embryos and inhibition of rickettsial growth was measured by the increase in survival time of the embryos. Previous findings that the parent strain is highly susceptible to p-aminobenzoic acid and that the inhibition by this drug is competitively reversed by p-hydroxybenzoic acid were confirmed. p-Hydroxybenzoic acid, which by itself did not inhibit any of the strains, also reversed the slight inhibition by p-aminobenzoic acid of psr and pr. The drug-resistant strains were inhibited by salicylic acid and acetylsalicylic acid to a larger extent than the parent strain and this drug susceptibility appeared to increase with resistance to p-aminobenzoic acid. Inhibition by acetylsalicylic acid was competitively reversed by p-aminobenzoic acid. The addition of p-hydroxybenzoic acid to a mixture of p-aminobenzoic acid and acetylsalicylic acid reestablished the inhibitory effect of used either alone or in combination with p-aminobenzoic acid or acetylsalicylic acid. An interpretation of the changes involved in the mutant strains, based on specifically balanced p-hydroxybenzoic and p-aminobenzoic acid requirements, and on competitions occurring at the enzymatic and specific transport sites, has been offered.
